Projects overview

Sort by

Toggle all information

Yellow4FLAVI | Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design

01-01-2024

-

31-12-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-17 Pandemic preparedness and response: Understanding vaccine induced-immunity

CCHFVACIM | Crimean-Congo Haemorrhagic Fever Vaccine and Immunotherapy

01-01-2024

-

31-12-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

FLAVIVACCINE | Development and characterization of a pan-flavivirus vaccine candidate

01-01-2024

-

31-12-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

LWNVIVAT | Limiting West Nile Virus impact by novel vaccines and therapeutics approaches

01-12-2023

-

30-11-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

MARVAX | Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protection

01-12-2023

-

30-11-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

SOLVE | Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness

01-01-2024

-

31-12-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-17 Pandemic preparedness and response: Understanding vaccine induced-immunity

VICI-DISEASE | PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINE

01-12-2023

-

30-11-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.5 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
Powered by Chris Decubber BV